JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/31/2024ACC: 0001867096-24-000016
Officer· See Remarks
Since Oct 2021
+175K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
175K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+175K
Price / share
—
Trade value
—
% of position
64.4%
1/31/2024
271.86K→446.86K
Total
Net shares
+175K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2024 | A · Award | +175K | — | — | 64.4% | 271.86K | 446.86K |
| Total | +175K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported